Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Baxalta Announces U.S. Availability of ADYNOVATE, A New Treatment for Adult Patients with Hemophilia A With a Simple, Twice-Weekly Dosing Schedule Nov 30, 2015 Nektar Therapeutics to Present at Jefferies Autumn 2015 Global Healthcare Conference in London Nov 17, 2015 Baxalta to Advance Care for Hemophilia A patients with FDA Approval of ADYNOVATE, a Simple, Twice-weekly Treatment to Reduce Bleeds Nov 16, 2015 Nektar Therapeutics Reports Financial Results for the Third Quarter of 2015 Nov 05, 2015 Nektar to Announce Financial Results for the Third Quarter 2015 on Thursday, November 5, 2015, After Close of U.S.-Based Financial Markets Oct 29, 2015 Nektar Reports on Advancements with Pain and Oncology Clinical Pipeline at Investor and Analyst R&D Day Oct 08, 2015 Nektar Submits Investigational New Drug Application (IND) for NKTR-214 To Treat Solid Tumor Malignancies Oct 07, 2015 Nektar Closes Direct Private Placement with TPG Special Situations Partners of $250 Million of Senior Secured Notes Due in 2020 Oct 06, 2015 Nektar to Host Research & Development Day for Analysts and Investors on October 8th Oct 01, 2015 Nektar Presents Data Demonstrating that NKTR-214, a CD122-Biased Immunostimulatory Cytokine, Induces Durable and Specific Anti-Tumor Immunity As a Single-Agent and When Combined with Checkpoint Inhibitors in Preclinical Models Sep 21, 2015 Pagination First page « first Previous page ‹ previous … Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Page 27 Page 28 … Next page next › Last page last »